Use of a subcutaneous implantable pleural port in the management of recurrent malignant pleurisy: five-year experience based on 168 subcutaneous implantable pleural ports.

Introduction: The authors report their experience in the use of subcutaneous implantable pleural port (SIPP) catheters for the treatment of symptomatic recurrent malignant pleurisy.

Materials And Methods: Single-center, prospective follow-up of 137 patients (168 SIPPs).

Results: No SIPP placement failures were observed.